Spindle cell oncocytoma of the pituitary and pituicytoma: Two tumors mimicking pituitary adenoma

Division of Neurosurgery, Northwestern University, Feinberg, School of Medicine, Chicago, Illinois, US.
Surgical Neurology International (Impact Factor: 1.18). 08/2011; 2:116. DOI: 10.4103/2152-7806.83932
Source: PubMed

ABSTRACT Spindle cell oncocytoma (SCO) and pituicytoma are rare nonfunctioning tumors of the pituitary. Both tumors are low grade and macroscopically indistinguishable from a nonfunctioning pituitary adenoma.We report one case of SCO and one case of pituicytoma and review the previous literature.
One patient was a 39-year-old man who presented with progressive headache, visual blurring, and polyuria of 3-year duration. He underwent partial resection (30% of the tumor) and postoperative adjuvant radiation therapy. Histopathology revealed SCO. However, after 9 months, the residual tumor grew and partial resection (70% of the tumor) was performed again. Four months after the second surgery, the tumor recurred again and he underwent transsphenoidal resection of the tumor with stable residual tumor to date. The other patient was a 59-year-old man who presented with a 3-month history of visual decline, fatigue, difficulty in writing, and polyuria. He underwent transsphenoidal resection (total) of the tumor. Histopathology revealed pituicytoma. He has been stable without evidence of recurrence for 1 year and 4 months.
To date, there are 15 reported cases of SCO and 45 reported cases of pituicytoma including our cases. An incomplete resection of the tumor was a significant risk factor for recurrence in both SCO and pituicytoma (P = 0.0014 and P = 0.019, respectively). These tumors have a tendency to be hypervascular, which may hamper total resection. Epithelial membrane antigen (EMA) and mitochondria positivity is characteristic to SCO and they are considered to be important immunomarkers to distinguish these tumors.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Spindle cell oncocytoma (SCO) is a non endocrine tumour that closely resembles a non functioning macroadenoma. SCO is composed of mitochondria-rich fusiform cells, positive for S-100 protein, vimentin, galectine-3, EMA and TTF1. Even though most SCOs have a benign course, a significant number of recidivant cases have been reported. We describe 2 cases of SCO, one of them with a late recurrence occurring 7 years after the initial diagnosis. The clinical and morphological features, immunohistochemistry and the probable origin of this unusual tumour are discussed.
    10/2013; 46(4):206–211. DOI:10.1016/j.patol.2013.05.002
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pituicytomas and spindle cell oncocytomas (SCOs) are extremely rare neoplasms of the sellar and suprasellar region that can often mimic pituitary adenomas. To date, there are relatively few cases of pituicytomas and SCOs reported; and most of these are small case series. In this paper, we provide a retrospective review of the treatment, imaging characteristics, post-operative course, and histopathology of five cases of pituicytomas and two SCOs treated at the University of California, San Francisco (UCSF) over a 10-year period from 2003 to 2013. We find that pituicytomas and SCOs present similarly to pituitary adenomas, and look identical on CT or MR imaging. We histopathologically confirmed all pituicytomas with a combination of hematoxylin and eosin morphology and immunohistochemical positivity for vimentin and S100; SCOs stain for anti-mitochondrial antigen and endothelial membrane antigen. We observe positive thyroid transcription factor 1 (TTF1) immunohistochemistry in both cases of SCO, as well as in both of the cases of pituicytoma in which TTF1 staining was available. This represents the largest single-institution case series of pituicytomas and SCOs to date, and also includes the first description of the management of a pregnant female with SCO. Our findings are consistent with the idea of common histogenesis for pituicytomas and SCOs, and also raise the possibility of more aggressive growth in SCOs as compared to pituicytomas.
    Pituitary 05/2014; 18(1). DOI:10.1007/s11102-014-0568-7 · 2.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pituicytomas are rare entities which develop in the neurohypophysis. They were included in the last World Health Organization (WHO) Classification of Central Nervous System Tumours in 2007, but for many years they have been confused with other pituitary tumours. We report the case of a 31-year-old woman who was diagnosed of a tumour in the suprasellar region during an infertility study due to hypogonadotropic hypogonadism and slight hyperprolactinemia. A standard pterional approach was performed, achieving total tumour excision. After the surgery the patient suffered bitemporal hemianopsia, diabetes insipidus and panhypopituitarism, although she recovered from the latter 2 in a few weeks. We conducted a review of the most common clinical and radiological features of this entity, as well as the treatments proposed in the literature to treat this rare tumour.
    Neurocirugia (Asturias, Spain) 07/2012; 23(4):165–169. DOI:10.1016/j.neucir.2012.03.001 · 0.32 Impact Factor